Radiation Injury
10
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
20%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases
Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications
Breast Cancer Lung Late Effects
Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment
Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI
Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*
Breath Test for Biomarkers in Humans Receiving Total Body Irradiation
Use of Large Field of View During Image Acquisition for Coronary Angiography
Abdominal Computed Tomography and the Blood Reactive Oxygen Species Level
Effect of Cardiac Computed Tomography Angiography on the Blood Reactive Oxygen Species Level